Actinium Pharma Stock (AMEX: ATNM) stock price, news, charts, stock research, profile.
Open | $6.900 |
Close | - |
Volume / Avg. | 215.222K / 361.644K |
Day Range | 6.880 - 7.480 |
52 Wk Range | 4.000 - 9.860 |
Market Cap | $215.770M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | AMEX |
RSI | 47 |
Short Interest | 7.44% |
Days to Cover | 2.19 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Actinium Pharma (AMEX: ATNM) through any online brokerage.
Other companies in Actinium Pharma’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Renovaro (NASDAQ:RENB), Innate Pharma (NASDAQ:IPHA), Galectin Therapeutics (NASDAQ:GALT) and Adverum Biotechnologies (NASDAQ:ADVM).
The latest price target for Actinium Pharma (AMEX: ATNM) was reported by HC Wainwright & Co. on Monday, April 29, 2024. The analyst firm set a price target for 50.00 expecting ATNM to rise to within 12 months (a possible 581.20% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Actinium Pharma (AMEX: ATNM) is $7.34 last updated Today at April 29, 2024 at 3:30 PM EDT.
There are no upcoming dividends for Actinium Pharma.
Actinium Pharma’s Q1 earnings are confirmed for Friday, April 26, 2024.
There is no upcoming split for Actinium Pharma.
Actinium Pharma is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.